NEW YORK (GenomeWeb) – N-of-One today announced that it has signed an agreement to provide clinical interpretations for GenomiCare's next-generation sequencing-based oncology panels in China.

N-of-One provides therapeutic strategies relevant to specific cancer cases based on genomic data. Shanghai-based GenomiCare uses NGS to identify mutations and copy number variations across a tumor's exome.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.